Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Open accessThe DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
The concept of molecular mimicry was established to explain commonalities of structure which developed in response to evolutionary pressures. Most examples of molecular mimicry in medicine have involved homologies of primary protein structure which cause disease. Molecular mimicry can be expanded beyond amino acid sequence to include microRNA and proteomic effects which are either pathogenic or salutogenic (beneficial) in regard to Parkinson's disease, Alzheimer's disease, and related disorders. Viruses of animal or plant origin may mimic nucleotide sequences of microRNAs and influence protein expression. Both Parkinson's and Alzheimer's diseases involve the formation of transmissible self-propagating prion-like proteins. However, the initiating factors responsible for creation of these misfolded nucleating factors are unknown. Amyloid patterns of protein folding are highly conserved through evolution and are widely distributed in the world. Similarities of tertiary protein structure may be involved in the creation of these prion-like agents through molecular mimicry. Cross-seeding of amyloid misfolding, altered proteostasis, and oxidative stress may be induced by amyloid proteins residing in bacteria in our microbiota in the gut and in the diet. Pathways of molecular mimicry induced processes induced by bacterial amyloid in neurodegeneration may involve TLR 2/1, CD14, and NFκB, among others. Furthermore, priming of the innate immune system by the microbiota may enhance the inflammatory response to cerebral amyloids (such as amyloid-β and α-synuclein). This paper describes the specific molecular pathways of these cross-seeding and neuroinflammatory processes. Evolutionary conservation of proteins provides the opportunity for conserved sequences and structures to influence neurological disease through molecular mimicry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Age-related perturbations in the gut microbiome have emerged as crucial factors contributing to age-related pathological conditions, including chronic inflammation,178 neurodegeneration,179 cognitive decline,180 and type 1 and type 2 diabetes.181”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“PD is characterized by accumulation of aggregated and phosphorylated AS in Lewy bodies and Lewy neurites [24] [25] [26].”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“It is estimated that there are 10X more cells and 130X more DNA in the metagenome than in our own bodies [40] [41].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Table 2 Agents inducing molecular mimicry REF Bacteria * [9] [44] [56] Animal viruses * [3] Plant viruses * [4] [5] [15] Amyloids proteins in food [50] [56] Bacteria that make amyloid proteins * * Xanthomonas axonopodis * Exogenous as well as endogenous (found in the microbiota).”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“ApoE, as a lipid-handling gene, influences bile acid secretion in humans and mucin secretion in murine lung, and has immunomodulatory effects [112] [113] [114] [115].”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 2×
“In particular, the importance of diversity of diet leading to diversity of the microbiota is a new concept, which is clinically important [45] [123].”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“The production of anti-inflammatory Treg cells may be enhanced by addition of " rationally selected " Clostridia strains [75].”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“Proteins from gut bacteria may gain access to neurons in the myenteric plexus because of the sampling of gut contents by epithelial microfold (M) cells as well as dendritic cells which deliver antigens to immune cells in Peyer’s patches [58, 59].”
Background
Research works printed but not linked: 1
- [103]103. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39, 51-68.
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513
“Other microbial molecules that mimic host structures have been suggested to CELL play roles in promoting immune responses during AD and PD (Friedland, 2015; Hill and Lukiw, 2015).”
BackgroundInflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
The gut microbiome in neurological disorders
Cryan, J. F., O'Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30356-4 · Cited by 1,336
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
“Bacterial amyloids might activate signaling pathways known to play a role in neurodegeneration and AD pathogenesis, while GM might enhance inflammatory responses to cerebral accumulation of Ab (155).”
BackgroundThe Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
“It has been hypothesized that functional amyloids produced by gut bacteria may be the source of misfolding of neuronal proteins such as alpha-synuclein, A (cid:2) via cross-seeding, priming of the innate immune system, and activation of neu-roinflammation [114, 115] (for review, see [114]).”
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
“It is possible that microglial cells primed with bacterial amyloid may be more responsive to Aβ in the brain.(26)”
BackgroundInfluentialMicrobiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Gut microbiome and aging: physiological and mechanistic insights
Nagpal, R., Mainali, R., Ahmadi, S., Wang, S., Singh, R., Kavanagh, K., Kitzman, D. W., Kushugulova, A., Marotta, F., & Yadav, H. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-170030 · Cited by 670
“The age-related perturbations in the 348 gut microbiome are also shown to be a important 349 contributing factor of age-associated pathological 350 states such as chronic inflammation [93], neurode351 generation [94], diabetes [95], non-alcoholic fatty 352 liver disease and cardiovascular disease [96].”
BackgroundBrain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
Westfall, S., Lomis, N., Kahouli, I., Dia, S. Y., Singh, S. P., & Prakash, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2550-9 · Cited by 541
“topic [5, 6, 18, 19, 37], so further elaboration will not be done here.”
BackgroundThe gut microbiome in human neurological disease: A review
Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496
Gut microbiota: A player in aging and a target for anti-aging intervention
Vaiserman, A. M., Koliada, A. K., & Marotta, F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.001 · Cited by 465
Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., et al. (2016) · Scientific Reports · doi:10.1038/srep34477 · Cited by 463
“We have hypothesized that amyloid proteins made by our commensal partners function to trigger misfolding of amyloid proteins such as AS through cross-seeding, and cause priming of the innate immune system thereby enhancing inflammatory responses to AS 4 .”
Self-citationThe microbiome of the upper respiratory tract in health and disease
Kumpitsch, C., Koskinen, K., Schöpf, V., & Moissl-Eichinger, C. (2019) · BMC Biology · doi:10.1186/s12915-019-0703-z · Cited by 465
Païssé, S., Valle, C., Servant, F., Courtney, M., Burcelin, R., Amar, J., & Lelouvier, B. (2016) · Transfusion · doi:10.1111/trf.13477 · Cited by 416
“We and others have previously demonstrated that bacteria, probably originating from the gut, can pass into tissues in the context of diseases such as cirrhosis, inflammatory diseases, sepsis, cardiovascular diseases, and diabetes.(5-15,36) In addition, despite the technical difficulties of cultivation of blood bacteri…”
BackgroundThe role of microbial amyloid in neurodegeneration
Friedland, R. P., & Chapman, M. R. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006654 · Cited by 391
Self-citationZhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
“These exhibit rapid and remarkably adaptive changes in LPS structure and alterations in damageor pathogen-associated molecular patterns (DAMP/PAMP) as strategies for host immune evasion (Friedland, 2015; Land, 2015; Maldonado et al., 2016; Richards et al., 2016).”
BackgroundThomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367
“Although the behavioral implications of these altered amyloid phenotypes requires elaboration, this intriguing study does provide support for the hypothesized role of the gut microbiota in neurodegenerative disorders (241).”
BackgroundSolfrizzi, V., Custodero, C., Lozupone, M., Imbimbo, B. P., Valiani, V., Agosti, P., Schilardi, A., D’Introno, A., La Montagna, M., Calvani, M., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170248 · Cited by 352
“Bacteria populating the microbiome have been shown to produce amyloids, lipopolysaccharides, and other immunogenic compounds [117, 118] that might contribute to the regulation of signaling pathways implicated in neuroinflammation, brain A deposition, and AD pathogenesis [116].”
The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology
Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Caputi, V., & Giron, M. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061689 · Cited by 338
Recent developments in understanding the role of the gut microbiota in brain health and disease
Sherwin, E., Dinan, T. G., & Cryan, J. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13416 · Cited by 338
Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota
Shabbir, U., Rubab, M., Daliri, E. B.-M., Chelliah, R., Javed, A., & Oh, D.-H. (2021) · Nutrients · doi:10.3390/nu13010206 · Cited by 334
“As GMD, priming the innate immune system by microbiota, determines a neuroinflammatory response that causes misfolding of neuronal amyloid-β and α-synuclein [117].”
BackgroundThe mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · The FEBS Journal · doi:10.1111/febs.15217 · Cited by 322
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
“The amyloids formed by bacteria are different from the CNS amyloids in the primary structure but show resemblance in their tertiary structure [120].”
BackgroundGut microbiota in neurodegenerative disorders
Roy Sarkar, S., & Banerjee, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.004 · Cited by 314
Microbiota-gut-brain axis and the central nervous system
Zhu, X., Han, Y., Du, J., Liu, R., Jin, K., & Yi, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17754 · Cited by 308
“Fireland [60] reported that bacterial proteins could cause inflammation, oxidative stress, and cytotoxicity and consequently induce or affect the progression of PD.”
BackgroundShen, L., Liu, L., & Ji, H.-F. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160884 · Cited by 277
“In addition, Friedland proposed the 243 potential pathways of molecular mimicry involving 244 the gut microbiota in the initiation and development 245 of neurodegenerative diseases [28].”
Microbiota medicine: towards clinical revolution
Gebrayel, P., Nicco, C., Al Khodor, S., Bilinski, J., Caselli, E., Comelli, E. M., Egert, M., Giaroni, C., Karpinski, T. M., Loniewski, I., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03296-9 · Cited by 276
“A new term “MAPraNosis” has been even proposed to describe the process of microbiotaassociated proteopathy and neuroinflammation [143].”
BackgroundUnhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“Thus, it is possible that the amyloid fibers produced by various bacterial species are capable of priming the peripheral immune system, and subsequently enhancing the neuroinflammatory responses to Aβ in the brain (Friedland, 2015).”
Therapies for Prevention and Treatment of Alzheimer’s Disease
Mendiola-Precoma, J., Berumen, L. C., Padilla, K., & Garcia-Alcocer, G. (2016) · BioMed Research International · doi:10.1155/2016/2589276 · Cited by 241
“The possible mechanisms that link microbiota to AD include (1) interactions between the gut microbiota and the CNS in a “microbiota-gut-brain axis” [123], which modify immune response, enhancing response to cerebral Aβ [126], (2) microbiota that could promote prion-like behavior of amyloid proteins leading to neurodeg…”
BackgroundMancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
“In addition, both bacterial-derived endotoxin and amyloid increase the levels of pro-inflammatory cytokines which transit from gut to brain where contribute to neurodegeneration by initiating immunogenic reactions [28,30,64].”
BackgroundTran, T. T. T., Corsini, S., Kellingray, L., Hegarty, C., Le Gall, G., Narbad, A., Müller, M., Tejera, N., O'Toole, P. W., Minihane, A.-M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900071r · Cited by 233
“Although the role of ApoE in gut chylomicron metabolism and in inflammation has been described, and gut microbiota modulation improves the cardio-metabolic profile in ApoE-deficient mice (Apoe) (21), the impact of APOE genotype on intestinal integrity and gut microbiome composition and metabolism is currently unknown…”
BackgroundCurcumin, Gut Microbiota, and Neuroprotection
Di Meo, F., Margarucci, S., Galderisi, U., Crispi, S., & Peluso, G. (2019) · Nutrients · doi:10.3390/nu11102426 · Cited by 214
“Gut dysbiosis, priming the innate immune system by microbiota, determines a neuroinflammatory response that causes misfolding of neuronal amyloid-β and α-synuclein [98].”
BackgroundAging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
Haran, J. P., & McCormick, B. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 216
Gut microbiota, cognitive frailty and dementia in older individuals: A systematic review
Ticinesi, A., Tana, C., Nouvenne, A., Prati, B., Lauretani, F., & Meschi, T. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s139163 · Cited by 215
“Bacterial amyloid proteins could then influence β-amyloid deposition in the brain with two different pathways: induction of neuroinflammation or molecular mimicry, that is, misfolding of neuronal proteins through cross-seeding.(98)”
BackgroundChidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Self-citationParkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 187
“Like prion disease, molecular mimicry-induced template cross-seeding may cause neuronal protein misfolding in PD [120].”
BackgroundLluch, J., Servant, F., Païssé, S., Valle, C., Valière, S., Kuchly, C., Vilchez, G., Donnadieu, C., Courtney, M., Burcelin, R., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142334 · Cited by 190
Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration
Solanki, R., Karande, A., & Ranganathan, P. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1149618 · Cited by 186
“As a result, gut exposure to bacterial amyloid proteins may prime the immune system, amplifying immune response to endogenous neuronal amyloid formation in the brain (54).”
BackgroundShort Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Ramos Meyers, G., Samouda, H., & Bohn, T. (2022) · Nutrients · doi:10.3390/nu14245361 · Cited by 184
Parkinson’s Disease and the Gastrointestinal Microbiome
Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172
“Age-related changes in the GM reflect decreased diversity of species [127], with corresponding decreases in microbial functional abundance [116].”
BackgroundThe Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Yang, D., Zhao, D., Ali Shah, S. Z., Wu, W., Lai, M., Zhang, X., Li, J., Guan, Z., Zhao, H., Li, W., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01155 · Cited by 162
The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
Engelberg, Y., & Landau, M. (2020) · Nature Communications · doi:10.1038/s41467-020-17736-x · Cited by 164
Time to test antibacterial therapy in Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Watling, M., & Imbimbo, B. P. (2019) · Brain · doi:10.1093/brain/awz244 · Cited by 161
Peterson, C. T. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20957225 · Cited by 160
“In addition, several potentially pathogenic gut residents such as Escherichia coli, Klebsiella pneumoniae, Mycobacterium tuberculosis, Salmonella enterica, Salmonella typhimurium, and Staphylococcus aureus, are known to produce amyloid proteins, which have been proposed as potential seeds in the formation of pathologi…”
BackgroundNair, A. T., Ramachandran, V., Joghee, N. M., Antony, S., & Ramalingam, G. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17105 · Cited by 155
“Recent investigations suggest that gut microbiota affects the brain activity through microbiotagut-brain axis under both physiological and pathological disease conditions like PD(25,51-53) through a prion like transmission via the molecular mimicry pathway.(54) Table 1.”
BackgroundNeuroinflammation, gut microbiome, and Alzheimer's disease
Lin, L., Zheng, L. J., & Zhang, L. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0983-2 · Cited by 147
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153
Ivanova, M. I., Lin, Y., Lee, Y., Zheng, J., & Ramamoorthy, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106507 · Cited by 160
Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).
Zhao, Y., & Lukiw, W. J. (2015) · PubMed · Cited by 174
Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease
Ihara, M., & Yamamoto, Y. (2016) · Stroke · doi:10.1161/strokeaha.115.009627 · Cited by 164
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 148
“Although the primary structures of bacterial and CNS amyloids are not similar, their tertiary structures reveal a significant similarity [82].”
BackgroundCaffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Ren, X., & Chen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602697 · Cited by 178
“…could act in a prion-like fashion and spread along the gut-brain axis via vagus nerve, eventually leading to the development of PD pathology (Friedland, 2015; Klingelhoefer and Reichmann, 2015; Pellegrini et al., 2018; Ho et al., 2019; Miraglia and Colla, 2019; Cirstea et al., 2020; Zheng…”
BackgroundDutta, S. K., Verma, S., Jain, V., Surapaneni, B. K., Vinayek, R., Phillips, L., & Nair, P. P. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19044 · Cited by 149
“It has been proposed by Friedland, that misfolding of these neuronal proteins found in PD, maybe triggered by molecular mimicry induced template cross-seeding similar to transmission of prion diseases in CNS.71 Cross-seeding is a phenomenon in which an endogenous or an exogenous protein may induce beta sheet misfoldin…”
BackgroundInfluentialEvolution of the Human Diet and Its Impact on Gut Microbiota, Immune Responses, and Brain Health
Olmo, B. M. G., Butler, M. J., & Barrientos, R. M. (2021) · Nutrients · doi:10.3390/nu13010196 · Cited by 179
Lai, Y., Liu, C.-W., Yang, Y., Hsiao, Y.-C., Ru, H., & Lu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-26209-8 · Cited by 145
Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease
de J.R. De-Paula, V., Forlenza, A. S., & Forlenza, O. V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.007 · Cited by 145
Jena, P. K., Sheng, L., Di Lucente, J., Jin, L., Maezawa, I., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201700984rr · Cited by 134
Neuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 145
Wang, H., Yang, F., Zhang, S., Xin, R., & Sun, Y. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00213-7 · Cited by 126
The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review
Ambrosini, Y. M., Borcherding, D., Kanthasamy, A., Kim, H. J., Willette, A. A., Jergens, A., Allenspach, K., & Mochel, J. P. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00130 · Cited by 126
“Intestinal dysbiosis can negatively influence gut physiology and lead to abnormal GBA signaling (Friedland, 2015), resulting in accumulation of misfolded amyloid species (Galloway et al., 2007; de Lartigue et al., 2011).”
BackgroundInfluentialThe Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 125
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 141
“Therefore, it has been proposed that bacterial amyloids cause neuroinflammation and induce protein aggregation, indirectly leading to neurodegeneration (123, 127, 128).”
BackgroundHow gut microbes could drive brain disorders
Willyard, C. (2021) · Nature · doi:10.1038/d41586-021-00260-3 · Cited by 124
Human Microbiome and its Association With Health and Diseases
Thani, A. A. A., Marei, H. E. S., Hamdi, W. S., Nasrallah, G. K., Zowalaty, M. E. E., Khodor, S. A., Al‐Asmakh, M., Aziz, H. A., & Cenciarelli, C. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25284 · Cited by 139
“…elicit the misfolding of a different JOURNAL OF CELLULAR PHYSIOLOGY molecule to cause cross-seeding of A b-aggregation in vitro (Morales et al., 2010) Cross-seeding of neurodegenerative disorder proteins may be induced by environmental amyloids such as those produced by bacteria (Friedland, 2015).”
BackgroundZhou, Y., Wang, Y., Quan, M., Zhao, H., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201497 · Cited by 136
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Dogra, N., Mani, R. J., & Katare, D. P. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01066-7 · Cited by 133
“2018a) Molecular mimicry: a mechanism where self-antigens share nucleotide sequences or structural similarities with foreign antigens (Friedland 2015).”
BackgroundMicrobiota modulation as preventative and therapeutic approach in Alzheimer’s disease
Bonfili, L., Cecarini, V., Gogoi, O., Gong, C., Cuccioloni, M., Angeletti, M., Rossi, G., & Eleuteri, A. M. (2021) · The FEBS Journal · doi:10.1111/febs.15571 · Cited by 115
Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets
Gao, Y., Li, D., Lin, J., Thomas, A. M., Miao, J., Chen, D., Li, S., & Chu, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.961661 · Cited by 128
“Accumulating evidence suggest a link between the gut microbiome and the development of cardiovascular diseases and neurodegenerative disorders (Karlsson et al., 2012; Friedland, 2015; Durgan et al., 2019; Sanchez-Rodriguez et al., 2020).”
BackgroundDysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Sharma, V., Singh, T. G., Garg, N., Dhiman, S., Gupta, S., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M. S., Albadrani, G. M., et al. (2021) · Biomolecules · doi:10.3390/biom11050678 · Cited by 117
“The gut amyloid may be the source of misfolding of neuronal proteins such as alphasynuclein and Aβ via cross seeding that ultimately prime the innate immune system and signal neuroinflammation [96].”
BackgroundMulak, A., Koszewicz, M., Panek-Jeziorna, M., Koziorowska-Gawron, E., & Budrewicz, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00992 · Cited by 110
“Additionally, the adaptive immune system may be disturbed by bacterial proteins cross-reacting with human antigens and cross-seeded misfolding via the molecular mimicry pathway (Friedland, 2015).”
BackgroundGut microbiota-derived metabolites and their importance in neurological disorders
Swer, N. M., Venkidesh, B. S., Murali, T. S., & Mumbrekar, K. D. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08038-0 · Cited by 132
“It has been reported that alteration in the composition of bacteria-producing metabolites may initiate and sustain the pathogenic processes of neurodegeneration [17].”
BackgroundPerov, S., Lidor, O., Salinas, N., Golan, N., Tayeb- Fligelman, E., Deshmukh, M., Willbold, D., & Landau, M. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007978 · Cited by 105
“Amyloid protein folding and aggregation patterns are highly conserved through evolution and appear in all kingdoms of life [61].”
BackgroundInfluentialUse of plant viruses and virus-like particles for the creation of novel vaccines
Baļķe, I., & Zeltiņš, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.007 · Cited by 117
Chen, J., Shi, X., Diao, M., Jin, G., Zhu, Y. J., Hu, W., & Xi, S. (2020) · BMC Emergency Medicine · doi:10.1186/s12873-020-00374-3 · Cited by 111
Wang, C., Lau, C. Y., Ma, F., & Zheng, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106504118 · Cited by 103
Microbiota and Aging. A Review and Commentary
García‐Peña, C., Álvarez‐Cisneros, T., Quiroz‐Baez, R., & Friedland, R. P. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.005 · Cited by 115
Self-citationThe Exceptional Vulnerability of Humans to Alzheimer’s Disease
Walker, L. C., & Jucker, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.001 · Cited by 104
Periodontitis, Microbiomes and their Role in Alzheimer’s Disease
Pritchard, A. B., Crean, S., Olsen, I., & Singhrao, S. K. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00336 · Cited by 97
“…Miklossy biofilm hypothesis, Friedland (2015) proposes a mechanism in which curli fibers and/or other similar bacterial antigens, with capacity to aggregate and acquire A β conformation would eventually grow by incorporating host A β and aggregate in the form of AD senile plaques (Friedland, 2015).”
InfluentialOlvera-Rosales, L. B., Cruz-Guerrero, A. E., Ramírez‐Moreno, E., Lira, A. Q., Contreras‐López, E., Ordaz, J. J., Ovando, A. C., Añorve‐Morga, J., Calderón‐Ramos, Z. G., Arias‐Rico, J., et al. (2021) · Foods · doi:10.3390/foods10061261 · Cited by 128
Westfall, S., Lomis, N., & Prakash, S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214985 · Cited by 95
Of microbes and minds: A narrative review on the second brain aging
Calvani, R., Picca, A., Lo Monaco, M. R., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00053 · Cited by 92
“As already outlined for AD, in neurodegenerative diseases, including PD, the passage of bacterial products from the intestine to the circulation and into brain, or “molecular mimicry” processes induced by bacterial amyloids may trigger a persistent neuroinflammation (28, 141, 142) that in turn contributes to neuronal…”
BackgroundTonomura, S., Ihara, M., Kawano, T., Tanaka, T., Okuno, Y., Saitô, S., Friedland, R. P., Kuriyama, N., Nomura, R., Watanabe, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep20074 · Cited by 97
Self-citationThe Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists
Lerner, A., Neidhöfer, S., & Matthias, T. (2017) · Microorganisms · doi:10.3390/microorganisms5040066 · Cited by 92
“Parkinson’s disease [84,113–128] Autism spectrum disorder [84,129–133] Amyotrophic lateral sclerosis [84,134–136] Alzheimer diseases [84,137–139] Prion diseases [81,84,94,139–147] Creutzfeldt-Jakob disease [81,143,145] Transmissible spongiform encephalopathies [84,139,143,145,146] Additional conditions Depression [148…”
BackgroundBrain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
Ferrosenescence: The iron age of neurodegeneration?
Sfera, A., Bullock, K., Price, A. I., Inderias, L., & Osorio, C. P. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.012 · Cited by 96
“Other studies suggested that bacterial cytokines may induce ER protein misfolding and oxidative stress with resultant neurodegeneration (253).”
BackgroundInterventions on Gut Microbiota for Healthy Aging
Zeppa, S. D., Agostini, D., Ferrini, F., Gervasi, M., Barbieri, E., Bartolacci, A., Piccoli, G., Saltarelli, R., Sestili, P., & Stocchi, V. (2022) · Cells · doi:10.3390/cells12010034 · Cited by 113
Fang, X. (2016) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1096271 · Cited by 86
“Accumulating evidence also suggests that microbiota may play a role in prion-like transmission via the molecular mimicry pathway [10].”
BackgroundThe gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Tarawneh, R. M., & Penhos, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104814 · Cited by 97
Is inflammageing influenced by the microbiota in the aged gut? A systematic review
Shintouo, C. M., Mets, T. F., Beckwée, D., Bautmans, I., Ghogomu, S. M., Souopgui, J., Leemans, L., Meriki, H. D., & Njemini, R. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111079 · Cited by 87
“…changes in gut microbiota have been shown to impact gut-brain axis in humans, thereby leading to diseases of the central nervous system such as anxiety, multiple sclerosis, depression, neurodegeneration and Alzheimer's disease (Collins et al., 2012; Luna and Foster, 2015; Friedland, 2015).”
BackgroundMicrobiota and neurodegenerative diseases
Marizzoni, M., Provasi, S., Cattaneo, A., & Frisoni, G. B. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000496 · Cited by 76
The microbiota, the gut and the brain in eating and alcohol use disorders: A ‘Ménage à Trois’?
Temko, J. E., Bouhlal, S., Farokhnia, M., Lee, M. R., Cryan, J. F., & Leggio, L. (2017) · Alcohol and Alcoholism · doi:10.1093/alcalc/agx024 · Cited by 76
“Finally, molecular mimicry has been implicated in a number of disease states, including autoimmune disorders (Hornig, 2013), Alzheimer’s disease, and Parkinson’s disease (Friedland, 2015), and it is associated with some health-promoting effects (Friedland, 2015).”
BackgroundThe Microbiota–Gut–Brain Axis and Epilepsy
Yue, Q., Cai, M., Xiao, B., Zhan, Q., & Zeng, C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01130-2 · Cited by 90
“Although many studies have shown that gut dysfunction/ dysbiosis has a hand in a variety of neurological diseases, such as anxiety, depression, and neurodegenerative diseases (Mulak and Bonaz 2015; Friedland 2015), and there are disorders of certain bioactive peptides (Lach et al.”
BackgroundZhao, H., Zhou, X., Song, Y., Zhao, W., Sun, Z., Zhu, J., & Yu, Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01683-0 · Cited by 90
Gut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 83
“Diet and specific nutrients seem to affect gut microbiota composition and influence the production and aggregation of amyloid proteins (Friedland 2015; Scott et al.”
Background
Metadata
- Authors
- Friedland, R. P.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Friedland, Robert P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2015-03-18
- Volume
- 45
- Issue
- 2
- Pages
- 349-362
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1526611045
- Cited by
- 338
- References
- 129
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 31 · 2023: 30 · 2022: 52 · 2021: 49 · 2020: 35 · 2019: 25 · 2018: 24 · 2017: 24 · 2016: 13 · 2015: 10
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- molecular mimicry, gut microbiota
- MeSH terms
- Animals, Humans, Cytokines, Molecular Mimicry, Neurodegenerative Diseases, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.